Liver Cancer
Copyright ©The Author(s) 2003.
World J Gastroenterol. Jan 15, 2003; 9(1): 65-68
Published online Jan 15, 2003. doi: 10.3748/wjg.v9.i1.65
Figure 5
Figure 5 Flow cytometry 4 days after medicinal treatment. (A). 1.0 µmol/L As2O3; (B). 1.0 g/L CDA-II; (C). 1.0 µmol/L As2O3 + 1.0 g/L CDA-II; (D). Control.